Skip to main navigation Skip to search Skip to main content

An AGITG trial –A randomised phase II study of pre-operative cisplatin, fluorouracil and DOCetaxel +/-radioTherapy based on poOR early response to cisplatin and fluorouracil for resectable esophageal adenocarcinoma

  • Andrew Barbour
  • , E Walpole
  • , G T Mai
  • , H Chan
  • , Elizabeth Barnes
  • , David Watson
  • , Steve Ackland
  • , V Wills
  • , J Martin
  • , Matthew Burge
  • , Chris Karapetis
  • , J Shannon
  • , Louise Nott
  • , Val Gebski
  • , K Wilson
  • , J Thomas
  • , Guy Lampe
  • , John Zalcberg
  • , John Simes
  • , Mark Smithers

Research output: Contribution to journal › Meeting Abstract › peer-review

Fingerprint

Dive into the research topics of 'An AGITG trial –A randomised phase II study of pre-operative cisplatin, fluorouracil and DOCetaxel +/-radioTherapy based on poOR early response to cisplatin and fluorouracil for resectable esophageal adenocarcinoma'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry